[Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
D000818:Animals; D005947:Glucose / Q000008:administration & dosage; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage / Q000494:pharmacology*; D014508:Urea / Q000008:administration & dosage / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D007328:Insulin; D014508:Urea; D014044:Tolbutamide; D005947:Glucose
Vergleichende Untersuchungen zwischen HB 419 (Glibenclamid) und Tolbutamid über ihre Wirkung auf die Insulinalbgabe an isolierten Inseln des Rattenpankreas in vitro.